- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CVRx Inc (CVRX)
The CVRx share price today is 5.64, view NASDAQ CVRX stock exchange data. Track the latest CVRx share price with real-time updates on CVRX stock performance including market cap, day range, 52-week range and dividend yield. Access CVRX charts, earnings dates and analyst estimates to support your investment decisions.
5.64
-0.14(-2.42%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.63
5.90
52 wk Range
4.37
11.30
CVRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.635.90
52 wk Range
4.3711.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CVRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
11.17
Upside
+97.99%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
6 Buy
0 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 11.17
(+97.99% Upside)
CVRx Inc SWOT Analysis
Barostim's Promise | Explore CVRx's innovative heart failure treatment, targeting a $3.7B market with strong revenue growth and impressive gross profit margins |
Reimbursement Hurdles | Learn about CVRx's critical reimbursement challenges, including the transition to Category I CPT codes and potential impacts on procedure pricing |
Adoption Challenges | Delve into the obstacles CVRx faces in increasing physician awareness and generating real-world evidence for broader Barostim adoption |
Financial Outlook | Analyst targets range from $13 to $22, with CVRx's growth potential justifying premium valuation multiples despite current unprofitability |
CVRx Inc Earnings Call Summary for Q1/2026
- CVRx Q1 2026 EPS of -$0.50 beat estimates of -$0.52; revenue of $14.8M topped forecast of $14.4M, driving stock up 1.32% to $6.83
- U.S. revenue surged 22% YoY while gross margin expanded 300bps to 87% on higher pricing and cost efficiencies; European market declined
- Q2 2026 revenue guidance set at $15.1M-$16.1M; full-year 2026 revenue expected to grow 20-25% to $63M-$67M
- CEO Yared highlighted strong U.S. Barostim therapy demand and BENEFIT-HF trial's potential to expand addressable market significantly
- Net loss narrowed to $13.1M from $13.8M YoY; challenges persist with continued losses, European weakness, and rising R&D/SG&A expenses
Last Updated: 12-05-2026, 03:02 am
Read Full TranscriptEarnings
Latest Release
11-05-2026
EPS / Forecast
-0.50 / -0.52
Revenue / Forecast
14.8M / 14.4M
Compare CVRX to Peers and Sector
Metrics to compare | CVRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCVRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.9x | −7.9x | −0.5x | |
PEG Ratio | −0.39 | −0.24 | 0.00 | |
Price/Book | 5.2x | 5.7x | 2.6x | |
Price / LTM Sales | 2.6x | 3.4x | 3.1x | |
Upside (Analyst Target) | 107.6% | 48.5% | 54.9% | |
Fair Value Upside | Unlock | −1.8% | 7.1% | Unlock |
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the CVRx (CVRX) Share Price Today?
The CVRx share price today is 5.64.
What is the current CVRx (CVRX) share price and day range?
As of 28-05-2026, the CVRx share price is 5.64, with a previous close of 5.78. The share price has ranged from 5.63 to 5.90 today, while the 52-week range spans from 4.37 to 11.30.
What Is the CVRx Market Cap?
As of today, CVRx market cap is 149.66M.
What Is the CVRx (CVRX) Share Price Target?
The average 12-month share price target for CVRx is 11.17, with a high estimate of 14 and a low estimate of 6. 6 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +97.99% Upside potential.
What Is CVRx's Earnings Per Share (TTM)?
The CVRx EPS (TTM) is -2.01.
When Is the Next CVRx Earnings Date?
CVRx will release its next earnings report on 04-08-2026.
From a Technical Analysis Perspective, Is CVRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does CVRx Trade On?
CVRx is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for CVRx?
The stock symbol for CVRx is "CVRX."
How Many Times Has CVRx Stock Split?
CVRx has split 0 times.
How Many Employees Does CVRx Have?
CVRx has 223 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.